Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

P16/MTS1 and pRB expression in endometrial carcinomas.

K Milde-Langosch1, L Riethdorf, A M Bamberger

  • 1Department of Gynecopathology, Institute of Pathology, University Clinics Eppendorf, Hamburg, Germany.

Virchows Archiv : an International Journal of Pathology
|March 10, 1999
PubMed
Summary

p16 and retinoblastoma protein (Rb) regulate cell cycle progression. This study found low p16 expression in most endometrial carcinomas, with rare genetic alterations in p16 and Rb, suggesting they are not primary drivers of endometrial cancer.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Categorization of uterine cervix tumors : What's new in the 2014 WHO classification].

Der Pathologe·2016
Same author

Prognostic impact of chondroitin-4-sulfotransferase CHST11 in ovarian cancer.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine·2015
Same author

Prognostic impact of transcription factor Fra-1 in ER-positive breast cancer: contribution to a metastatic phenotype through modulation of tumor cell adhesive properties.

Journal of cancer research and clinical oncology·2015
Same author

c-FOS suppresses ovarian cancer progression by changing adhesion.

British journal of cancer·2013
Same author

MicroRNAs miR-371-3 in serum as diagnostic tools in the management of testicular germ cell tumours.

British journal of cancer·2012
Same author

[Diagnosis and differential diagnosis of cervical adenocarcinoma].

Der Pathologe·2011

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Cycle Regulation

Background:

  • p16MTS1/CDKN1 and retinoblastoma protein (Rb) are tumor suppressors regulating G1/S phase transition.
  • Inactivation of p16 or Rb is common in malignancies, with some studies suggesting an inverse correlation in expression.
  • Understanding the interplay of p16 and Rb is crucial in endometrial carcinogenesis.

Purpose of the Study:

  • To investigate the interaction and expression patterns of p16 and Rb in endometrial carcinogenesis.
  • To determine the frequency of genetic alterations in p16 and Rb during endometrial cancer development.

Main Methods:

  • Immunohistochemistry and RT-PCR were used to assess p16 and Rb expression in endometrial tissues and cell lines.
  • Deletion and mutation analyses of the p16 gene were performed on microdissected tumor samples and cell lines.

Related Experiment Videos

Main Results:

  • Rb was widely expressed in normal endometrium, hyperplasia, and most carcinomas.
  • p16 expression was low in normal endometrium, increased in hyperplasia, but was negative or minimally positive in 74% of carcinomas.
  • No significant association was found between p16 and Rb immunostaining; p16 gene deletions or mutations were rare in endometrial tumors.

Conclusions:

  • Genetic alterations of p16 and Rb are infrequent in endometrial carcinogenesis despite typically low p16 expression in tumors.
  • The study suggests that p16 and Rb may not be the primary drivers of endometrial carcinogenesis, though their roles in specific contexts like squamous metaplasia warrant further investigation.